BIOMAT Database Logo BIOMAT Database Logo

[Synthesis and pharmacological activity of 2,3-dihydro-1H-pyrazolo-[1,2-a]indazolium derivatives]. 1986

Y Fujimura, and Y Shiraki, and Y Nawata, and I Matsunaga

UI MeSH Term Description Entries
D007191 Indazoles A group of heterocyclic aromatic organic compounds consisting of the fusion of BENZENE and PYRAZOLES. Indazole
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D001993 Bronchodilator Agents Agents that cause an increase in the expansion of a bronchus or bronchial tubes. Bronchial-Dilating Agents,Bronchodilator,Bronchodilator Agent,Broncholytic Agent,Bronchodilator Effect,Bronchodilator Effects,Bronchodilators,Broncholytic Agents,Broncholytic Effect,Broncholytic Effects,Agent, Bronchodilator,Agent, Broncholytic,Agents, Bronchial-Dilating,Agents, Bronchodilator,Agents, Broncholytic,Bronchial Dilating Agents,Effect, Bronchodilator,Effect, Broncholytic,Effects, Bronchodilator,Effects, Broncholytic
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Y Fujimura, and Y Shiraki, and Y Nawata, and I Matsunaga
[Synthesis of substituted 1,2-malonyl-1,2-dihydroquinolines (1,3-dioxo-2,3-dihydro-1H-pyrazolo(1,2-alpha)quinolines) with anti-inflammatory characteristics].
January 1968, Helvetica chimica acta,
Y Fujimura, and Y Shiraki, and Y Nawata, and I Matsunaga
Modular Synthesis and Antiproliferative Activity of New Dihydro-1H-pyrazolo[1,3-b]pyridine Embelin Derivatives.
October 2021, Pharmaceuticals (Basel, Switzerland),
Y Fujimura, and Y Shiraki, and Y Nawata, and I Matsunaga
Synthesis and pharmacological evaluation of 2,3-dihydro-1H-thieno(2,3-e)(1,4)diazepines.
June 1974, Journal of medicinal chemistry,
Y Fujimura, and Y Shiraki, and Y Nawata, and I Matsunaga
Pharmacologic potency and selectivity of a new bronchodilator agent, 2,3-dihydro-7-methyl-9-phenyl-1H-pyrazolo [1,2-a] indazolium bromide (FKK) on canine tracheal preparations "in vivo" and "in vitro".
March 1983, Archives internationales de pharmacodynamie et de therapie,
Y Fujimura, and Y Shiraki, and Y Nawata, and I Matsunaga
Synthesis and benzodiazepine receptor activity of some 4,5-dihydro-1H-pyrazolo[4,3-c][1,8]naphthyridine derivatives.
June 1994, Drug design and discovery,
Y Fujimura, and Y Shiraki, and Y Nawata, and I Matsunaga
2,3-Dihydro-1H-pyrrolo-[1,2-a]indole-9-carbonitrile.
December 2012, Acta crystallographica. Section E, Structure reports online,
Y Fujimura, and Y Shiraki, and Y Nawata, and I Matsunaga
Absolute Configuration Determination of 2,3-Dihydro-1H,5H-pyrazolo[1,2-a]pyrazoles Using Chiroptical Methods at Different Wavelengths.
December 2016, The Journal of organic chemistry,
Y Fujimura, and Y Shiraki, and Y Nawata, and I Matsunaga
Synthesis and ribonucleotide reductase inhibitory activity of analogues of 2,3-dihydro-1H-imidazo[1,2-b]pyrazole (IMPY).
December 1987, Anti-cancer drug design,
Y Fujimura, and Y Shiraki, and Y Nawata, and I Matsunaga
2,3-Dihydro-1H-imidazo(1,2-b)pyrazole: a new inhibitor of deoxyribonucleic acid synthesis.
October 1971, Biochemical pharmacology,
Y Fujimura, and Y Shiraki, and Y Nawata, and I Matsunaga
Synthesis, SAR study, and biological evaluation of novel 2,3-dihydro-1H-imidazo[1,2-a]benzimidazole derivatives as phosphodiesterase 10A inhibitors.
August 2019, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!